ALEXANDRA MULLINS: Open Payments
NPI 1689224867 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,021 in 55 payments from 19 companies in 2025. Trend: 2023 $774 · 2024 $1,175 · 2025 $1,021
Food & beverage: $1,021
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $314 |
| Amgen Inc. | 7 | $183 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| Lilly USA, LLC | 3 | $53 |
| ABBVIE INC. | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Daiichi Sankyo Inc. | 2 | $29 |
| Grifols USA, LLC | 1 | $28 |
Products named: REPATHA, Rybelsus, Wegovy, QULIPTA, Ozempic, Kerendia, NEFFY, SHINGRIX.
Industry payments across NC — which companies pay providers there.
